1. Home
  2. PODD

as 05-24-2024 4:00pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Medical/Dental Instruments

Nasdaq

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

Founded: 2000 Country:
United States
United States
Employees: N/A City: ACTON
Market Cap: 12.9B IPO Year: 2007
Target Price: $239.07 AVG Volume (30 days): 936.6K
Analyst Decision: Buy Number of Analysts: 15
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 3.33 EPS Growth: 33200.00
52 Week Low/High: $125.82 - $298.95 Next Earning Date: 05-09-2024
Revenue: $1,780,700,000 Revenue Growth: 30.17%
Revenue Growth (this year): 17.91% Revenue Growth (next year): 18.54%

Share on Social Networks:

Stock Insider Trading Activity of Insulet Corporation (PODD)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Petrovic Shacey PODD Director Feb 28 '24 Sell $162.92 11,609 $1,891,338.28 2,567 SEC Form 4
BORIO LUCIANA PODD Director Dec 15 '23 Sell $207.08 72 $14,909.76 2,278 SEC Form 4
Petrovic Shacey PODD Director Nov 13 '23 Sell $165.02 2,075 $342,416.50 41,130 SEC Form 4
Petrovic Shacey PODD Director Nov 13 '23 Sell $165.02 12,925 $2,132,883.50 0 SEC Form 4
Petrovic Shacey PODD Director Nov 13 '23 Sell $164.33 20,000 $3,286,600.00 2,567 SEC Form 4